BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 12477702)

  • 21. A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities.
    Fisher PG; Breiter SN; Carson BS; Wharam MD; Williams JA; Weingart JD; Foer DR; Goldthwaite PT; Tihan T; Burger PC
    Cancer; 2000 Oct; 89(7):1569-76. PubMed ID: 11013373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up.
    Lama G; Esposito Salsano M; Grassia C; Calabrese E; Grassia MG; Bismuto R; Melone MA; Russo S; Scuotto A
    Minerva Pediatr; 2007 Feb; 59(1):13-21. PubMed ID: 17301720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Presentation and Outcome of Patients With Optic Pathway Glioma.
    Robert-Boire V; Rosca L; Samson Y; Ospina LH; Perreault S
    Pediatr Neurol; 2017 Oct; 75():55-60. PubMed ID: 28847625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment Endocrine Disorders Due to Optic Pathway Gliomas in Pediatric Neurofibromatosis Type 1: Multicenter Study.
    Santoro C; Perrotta S; Picariello S; Scilipoti M; Cirillo M; Quaglietta L; Cinalli G; Cioffi D; Di Iorgi N; Maghnie M; Gallizia A; Parpagnoli M; Messa F; De Sanctis L; Vannelli S; Marzuillo P; Miraglia Del Giudice E; Grandone A
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32294191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatments for astrocytic tumors in children: current and emerging strategies.
    Burzynski SR
    Paediatr Drugs; 2006; 8(3):167-78. PubMed ID: 16774296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurofibromatosis type 1 and the pediatric neurosurgeon: a 20-year institutional review.
    Farmer JP; Khan S; Khan A; Ortenberg J; Freeman C; O'Gorman AM; Montes J
    Pediatr Neurosurg; 2002 Sep; 37(3):122-36. PubMed ID: 12187057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multi-institutional study of brainstem gliomas in children with neurofibromatosis type 1.
    Mahdi J; Shah AC; Sato A; Morris SM; McKinstry RC; Listernick R; Packer RJ; Fisher MJ; Gutmann DH
    Neurology; 2017 Apr; 88(16):1584-1589. PubMed ID: 28330960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late-onset optic pathway tumors in children with neurofibromatosis 1.
    Listernick R; Ferner RE; Piersall L; Sharif S; Gutmann DH; Charrow J
    Neurology; 2004 Nov; 63(10):1944-6. PubMed ID: 15557519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurofibromatosis type 1 and precocious puberty.
    Virdis R; Sigorini M; Laiolo A; Lorenzetti E; Street ME; Villani AR; Donadio A; Pisani F; Terzi C; Garavelli L
    J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():841-4. PubMed ID: 10969931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of surgery in optic pathway/hypothalamic gliomas in children.
    Goodden J; Pizer B; Pettorini B; Williams D; Blair J; Didi M; Thorp N; Mallucci C
    J Neurosurg Pediatr; 2014 Jan; 13(1):1-12. PubMed ID: 24138145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Favorable prognosis in pediatric brainstem low-grade glioma: Report from the German SIOP-LGG 2004 cohort.
    Holzapfel J; Kandels D; Schmidt R; Pietsch T; Warmuth-Metz M; Bison B; Krauss J; Kortmann RD; Timmermann B; Thomale UW; Albert MH; Hernáiz Driever P; Witt O; Gnekow AK
    Int J Cancer; 2020 Jun; 146(12):3385-3396. PubMed ID: 31613986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of childhood CNS tumours in Britain and variation in rates by definition of malignant behaviour: population-based study.
    Stiller CA; Bayne AM; Chakrabarty A; Kenny T; Chumas P
    BMC Cancer; 2019 Feb; 19(1):139. PubMed ID: 30744596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors and survival in primary adult high grade brainstem astrocytoma: a population based study from 1973-2008.
    Dey M; Lin Y; Melkonian S; Lam S
    J Clin Neurosci; 2014 Aug; 21(8):1298-303. PubMed ID: 24674698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1.
    Evans DGR; Salvador H; Chang VY; Erez A; Voss SD; Schneider KW; Scott HS; Plon SE; Tabori U
    Clin Cancer Res; 2017 Jun; 23(12):e46-e53. PubMed ID: 28620004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas.
    Tucker T; Friedman JM; Friedrich RE; Wenzel R; Fünsterer C; Mautner VF
    J Med Genet; 2009 Feb; 46(2):81-5. PubMed ID: 18930997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-optic glioma in adults and children with neurofibromatosis 1.
    Sellmer L; Farschtschi S; Marangoni M; Heran MK; Birch P; Wenzel R; Friedman JM; Mautner VF
    Orphanet J Rare Dis; 2017 Feb; 12(1):34. PubMed ID: 28202035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereotactic radiosurgery for pilocytic astrocytomas when multimodal therapy is necessary.
    Hadjipanayis CG; Kondziolka D; Gardner P; Niranjan A; Dagam S; Flickinger JC; Lunsford LD
    J Neurosurg; 2002 Jul; 97(1):56-64. PubMed ID: 12134933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The management of brainstem gliomas in patients with neurofibromatosis 1.
    Pollack IF; Shultz B; Mulvihill JJ
    Neurology; 1996 Jun; 46(6):1652-60. PubMed ID: 8649565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural history and clinical management of optic pathway glioma.
    Astrup J
    Br J Neurosurg; 2003 Aug; 17(4):327-35. PubMed ID: 14579898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.